Journal Club

Does Anti-CD20 Treatment Affect Response to COVID-19 Vaccines in Patients With Multiple Sclerosis? Review of a Pilot Study

Anti-CD20 Therapy: Remodeling Potential in the Treatment of Multiple Sclerosis